| BARINTHUS BIOTHERAPEUTICS ADR |
| USA |
| Gesundheit |
| US91864C1071 / A3CN5Q |
| 2AB (Frankfurt) / BRNS (NASDAQ) |
| FRA:2AB, ETR:2AB, 2AB:GR, NASDAQ:BRNS |
| - |
| https://www.barinthusbio... |
|
Barinthus Biotherapeutics plc American Depositary Shares is a biopharmaceutical security representing ownership in Barinthus Biotherapeutics plc, a clinical-stage company focused on immunology and inflammation. The company develops antigen-specific i..
>Volltext.. |
| 26.7 Mio. EUR |
| -15.73 Mio. EUR |
| - |
| -25.04 Mio. EUR |
| -35.88 Mio. EUR |
| -0.88 EUR |
| 8.87 Mio. EUR |
| 51.35 Mio. EUR |
| -22.61 Mio. EUR |
| 5.22 |
| -100% |
| 40.18% |
| - |
| - |
| - |
| - |
| BARINTHUS |
| 11.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|